Guardant Health Inc (GH) — Quality & forensics
As of 2026-09-24 — refreshed nightly. Closelook readings from an investment research diary, not ratings or advice.
The Closelook module scores
- Valuation 10
- Quality 17
- Growth 68
- Balance sheet 53
- Cash quality 64
- Capital allocation 22
- Momentum 92
Scores are computed nightly across the coverage universe and read relative to it — the methodology lives in the company-scoring explainer.
Financial forensics — the academic screens
Sits in the safe zone (above 2.99). The Z-Score estimates financial-distress risk from five balance-sheet and earnings ratios.
Nine binary fundamental-strength checks across profitability, leverage and operating efficiency.
Screens reported earnings for statistical manipulation patterns — below the −1.78 manipulation-risk threshold. A screen, not an accusation.
Continue: the GH chart & overview · the earnings record
FAQ · from the current data · as of 2026-09-24
Quick answers
What is Guardant Health Inc's Closelook quality reading?
The composite reads 44/100 across 7 modules, as of 2026-09-24: valuation 10, quality 17, growth 68, balance sheet 53, cash quality 64, capital allocation 22, momentum 92. Closelook scores are research diary readings, not ratings or investment advice.
What is Guardant Health Inc's Altman Z-Score?
5.10, which sits in the safe zone (above 2.99) as of 2026-09-24. The Altman Z-Score estimates financial distress risk from five balance-sheet and earnings ratios.
What is Guardant Health Inc's Piotroski F-Score?
5 of 9, as of 2026-09-24. The F-Score counts nine binary fundamental-strength signals across profitability, leverage and operating efficiency.
What does Guardant Health Inc's Beneish M-Score indicate?
-2.78 — below the −1.78 manipulation-risk threshold, as of 2026-09-24. The M-Score screens reported earnings for statistical manipulation patterns; it is a screen, not an accusation.
Related in the Closelook universe
then Diagnostics & Research. Scored names rank on their Closelook score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.
- MEDP Medpace Holdings Incindustry
- IDXX IDEXX Laboratories Incindustry
- ILMN Illumina Incindustry
- ICLR ICON PLCindustry
- NTRA Natera Incindustry
- RVTY Revvity Inc.industry
- A Agilent Technologies Incindustry
- TMO Thermo Fisher Scientific Incindustry
- IQV IQVIA Holdings Incindustry
- WGS GeneDx Holdings Corp.industry
- CRL Charles River Laboratoriesindustry
- MTD Mettler-Toledo International Incindustry
- DHR Danaher Corporationindustry
- WAT Waters Corporationindustry
- QGEN Qiagen NVindustry
- VCYT Veracyte Incindustry
- DGX Quest Diagnostics Incorporatedindustry
- RDNT RadNet Incindustry
- SHC Sotera Health Coindustry
- LH Laboratory Corporation of America Holdingsindustry